[
  {
    "question": "Patient inattentive LFT, Electrolyte & CT brain are normal, what explains that?",
    "option_a": "brain infection",
    "option_b": "systemic infection",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "This question deals with altered mental status presenting as inattentiveness. When neuroimaging (CT brain) and basic laboratory studies (LFTs, electrolytes) are normal, a systemic process such as an infection can lead to an encephalopathic state called sepsis-associated encephalopathy (delirium). Systemic infections can trigger a cytokine-mediated inflammatory response that affects the central nervous system. Disruption of the blood-brain barrier and neuroinflammation can cause diffuse cerebral dysfunction without necessarily producing focal neurological deficits or abnormal CT findings, a hallmark of toxic-metabolic encephalopathies. Patients with systemic infections (sepsis) may present with inattention, confusion, or delirium even when brain imaging is normal. This form of encephalopathy is commonly seen in the elderly or those with multiple comorbidities, and the absence of liver or electrolyte abnormalities helps exclude other metabolic causes. The evaluation of altered mental status involves excluding structural brain lesions (using CT or MRI), assessing metabolic parameters (electrolytes, LFTs), and identifying systemic infections through cultures and inflammatory markers. Differential diagnoses include primary brain infection (meningitis or encephalitis), nonconvulsive seizures, and other toxic-metabolic disturbances. Management focuses on treating the underlying infection with appropriate antibiotics and supportive care. In patients with sepsis-associated delirium, early identification and management of sepsis are crucial. In pregnant or lactating patients, antibiotic choices should balance efficacy with fetal/neonatal safety, often using agents with established safety profiles in these populations. Option B (Systemic infection) is correct because it identifies sepsis as the likely underlying cause of encephalopathy in the setting of normal CT and laboratory studies. Option A (brain infection) would usually be accompanied by focal neurological deficits and abnormal imaging findings, making it less likely in this scenario. 1. Always suspect sepsis in patients with delirium even if initial laboratory and imaging studies are normal. 2. Early recognition and management of sepsis improve outcomes. 3. Delirium in systemic infection is typically reversible with appropriate treatment. Recent clinical guidelines emphasize the importance of early sepsis recognition and management, highlighting that sepsis-associated encephalopathy can present with subtle cognitive changes despite normal imaging. Current research supports multimodal management, including both antimicrobial therapy and supportive measures.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Sickle cell anemia patient with low back pain and fever asked about the organism?",
    "option_a": "Staphylococcus aureus",
    "option_b": "Pseudomonas aeruginosa",
    "option_c": ", interpreted as Salmonella (the presumed intended organism), is correct in the context of sickle cell disease. Option A (Staphylococcus aureus) is a common cause in the general population but less so in SCD. Option B (Pseudomonas aeruginosa) is rare in this setting. Thus, the marked answer correctly identifies the most likely pathogen.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "Sickle cell disease (SCD) predisposes patients to osteomyelitis due to repeated vaso-occlusive events which cause bone infarctions. Unlike the general population where Staphylococcus aureus is most common, patients with SCD are particularly vulnerable to Salmonella osteomyelitis. In SCD, microvascular occlusions lead to bone infarcts and ischemia, creating an environment conducive to bacterial seeding. Impaired splenic function (autosplenectomy) further reduces the body\u2019s ability to clear encapsulated organisms, favoring infections by Salmonella, which can translocate from the gut. A patient with SCD presenting with low back pain and fever should raise suspicion for osteomyelitis. Salmonella osteomyelitis often has an insidious course, and the history of SCD tips the diagnostic scale away from the more common S. aureus seen in the general population. Evaluation includes blood cultures, inflammatory markers (ESR, CRP), and imaging studies such as MRI to detect bone involvement. Bone biopsy may be necessary to definitively identify the causative organism and differentiate Salmonella osteomyelitis from other causes like Staphylococcus aureus or Pseudomonas. Management involves prolonged antibiotic therapy guided by culture and sensitivity results. First-line treatment typically includes a third-generation cephalosporin or a fluoroquinolone, accounting for Salmonella\u2019s susceptibility profile. In cases of complications or abscess formation, surgical intervention may be necessary. In pregnant or lactating women, antibiotic selections should be made carefully, preferring agents with proven safety profiles (for example, ceftriaxone is commonly used). Option C, interpreted as Salmonella (the presumed intended organism), is correct in the context of sickle cell disease. Option A (Staphylococcus aureus) is a common cause in the general population but less so in SCD. Option B (Pseudomonas aeruginosa) is rare in this setting. Thus, the marked answer correctly identifies the most likely pathogen. 1. In patients with SCD and osteomyelitis, always consider Salmonella as the likely pathogen. 2. The impaired splenic function in SCD increases susceptibility to encapsulated organisms. 3. Early aggressive treatment can prevent chronic osteomyelitis and associated complications. Recent studies and reviews continue to support Salmonella as the predominant cause of osteomyelitis in sickle cell patients. Ongoing research is focused on antibiotic resistance patterns and optimizing duration of therapy, with current guidelines recommending culture-directed treatment.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Patient from India found to have schistosomiasis, Treatment?",
    "option_a": "praziquantel",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Schistosomiasis is a parasitic infection caused by trematode worms of the genus Schistosoma. Praziquantel is the treatment of choice due to its efficacy in killing the adult worms, thereby reducing egg deposition and limiting tissue damage. Schistosome parasites penetrate the skin and migrate via the bloodstream to specific organs where adult worms reside. The deposition of eggs in tissues, such as the liver, bladder, or intestines, leads to granulomatous inflammation and fibrosis. Praziquantel acts by increasing the permeability of the parasite\u2019s cell membranes to calcium ions, resulting in paralysis and death. Residents or travelers from endemic regions (including certain areas in India) who present with signs of chronic schistosomiasis (e.g., abdominal pain, hepatosplenomegaly, hematuria) are typically managed with praziquantel. Timely treatment reduces morbidity by minimizing long-term complications such as portal hypertension or bladder cancer in cases of Schistosoma haematobium. Diagnosis is based on identification of eggs in stool or urine samples, serological tests, or tissue biopsy in ambiguous cases. Differential diagnoses include other parasitic and fungal infections, but the presence of characteristic eggs confirms schistosomiasis. Praziquantel is the first-line treatment; the dosing regimen varies by Schistosoma species and disease burden. For most patients, a single-day treatment course is effective. In pregnant and lactating women, current WHO guidelines indicate that praziquantel can be used if indicated, as emerging data support its safety profile in these populations. Option A (praziquantel) is correct since it is the recommended and widely accepted treatment for schistosomiasis. There are no superior alternatives for first-line treatment, making this the clear choice. 1. Early diagnosis and treatment of schistosomiasis can prevent chronic complications such as portal hypertension and bladder carcinoma. 2. Always consider travel or residence history in patients with unexplained organomegaly or hematuria. 3. Praziquantel remains the gold standard for treatment despite ongoing research into vaccine development. The latest research and guidelines from the WHO and CDC reinforce the use of praziquantel as the mainstay therapy for schistosomiasis. Recent studies have confirmed its efficacy and safety profile even when used in pregnant and lactating women, with ongoing research aimed at enhancing treatment strategies and drug formulations.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Brucella case, patient came from Africa, Treatment?",
    "option_a": "Doxycycline",
    "option_b": "Ceftriaxone",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Brucellosis is a zoonotic infection caused by Brucella species. The disease is commonly contracted from animals or animal products and is endemic in certain regions, including parts of Africa. Its treatment centers on antibiotics that can penetrate intracellularly, as Brucella is an intracellular organism. Brucella organisms are gram\u2010negative coccobacilli that target the reticuloendothelial system. They survive and multiply within phagocytes, which is why agents that achieve good intracellular penetration (such as doxycycline) are central to therapy. Standard treatment involves combination therapy to reduce relapse rates, typically doxycycline with rifampin. Patients with brucellosis usually present with undulant fever, malaise, arthralgias, and sometimes hepatosplenomegaly. A high clinical suspicion is warranted especially in patients from endemic regions. Laboratory confirmation is done with serological tests or blood cultures. Differential diagnoses include tuberculosis, malaria, and other causes of fever of unknown origin. Laboratory confirmation via blood cultures or serologic tests (e.g., standard agglutination test) is important. It is crucial to note that the intracellular nature of Brucella requires treatments that reach intracellular compartments. According to current guidelines, the first-line treatment regimen for brucellosis is a combination of doxycycline (100 mg orally twice daily for at least 6 weeks) and rifampin (600-900 mg daily). In cases with complications (e.g., osteoarticular involvement), an aminoglycoside may be added. In pregnancy, doxycycline is contraindicated; alternatives such as rifampin combined with safe agents (keeping in mind trimethoprim-sulfamethoxazole is avoided in the first trimester) should be considered. Option A (Doxycycline) is correct in that doxycycline is a cornerstone in the treatment of brucellosis due to its excellent intracellular penetration. Option B (Ceftriaxone) is not typically used for brucellosis; it does not have ideal efficacy against Brucella organisms, and thus is not the treatment of choice. 1. Brucellosis treatment requires prolonged combination antibiotic therapy to prevent relapse. 2. Doxycycline, while first-line, should not be used in pregnancy. 3. Always consider the patient\u2019s geographic exposure when evaluating for brucellosis. The most recent guidelines and studies from CDC and WHO reiterate the use of combination regimens (doxycycline plus rifampin) as first-line therapy, with modifications based on patient-specific factors such as pregnancy and focal complications.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "HIV Patient with non-enhancing white matter mass on MRI, Patient was not compliant to HAART, rx?",
    "option_a": "HAART",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV-positive patients, central nervous system (CNS) lesions are often due to opportunistic infections or neoplasms arising from immunosuppression. A non-enhancing white matter lesion, particularly in someone non-compliant with highly active antiretroviral therapy (HAART), is most consistent with progressive multifocal leukoencephalopathy (PML). PML is caused by reactivation of the JC virus in immunocompromised patients. The virus infects oligodendrocytes, leading to demyelination. The lesion typically does not enhance because it is not associated with a robust inflammatory response, which is why contrast studies show non-enhancing white matter abnormalities. Patients with PML may present with focal neurological deficits, cognitive decline, and motor weakness. The radiological hallmark is multifocal, often confluent non-enhancing white matter lesions. The patient\u2019s poor compliance with HAART is a key risk factor, as effective antiretroviral therapy helps maintain immune surveillance against JC virus reactivation. Differential diagnoses for white matter lesions in HIV include CNS lymphoma (which generally shows contrast enhancement), toxoplasmosis (typically ring-enhancing lesions), and other demyelinating disorders. Diagnosis mainly relies on clinical history, MRI findings, and sometimes cerebrospinal fluid analysis with JC virus PCR testing. The cornerstone of PML management is immune reconstitution via HAART. There are no effective direct antiviral treatments against the JC virus. Early initiation or optimization of HAART is critical. In patients who are pregnant or lactating, HAART regimens should be carefully selected based on safety profiles; fortunately, many recommended HAART drugs are considered safe in pregnancy with appropriate regimen adjustments. Option A (HAART) is correct because restoring immune function is the only proven intervention that may improve outcomes in PML. Other treatment options have not demonstrated efficacy, and therefore the focus remains on antiretroviral therapy compliance. 1. Always consider PML in HIV patients with non-enhancing white matter lesions. 2. Immune reconstitution via HAART is the main treatment for PML. 3. Contrast enhancement is more typical of lymphoma or toxoplasmosis in HIV patients. Recent studies and guideline updates emphasize that the prognosis of PML is closely tied to the timely initiation of HAART. Although research into direct anti-JC virus therapies continues, current management remains supportive and centers on optimizing immune recovery.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Common meningitis in elderly with poorly controlled DM?",
    "option_a": "Listeria + strep + pneumonic",
    "option_b": "HIV + Cryptococcus",
    "option_c": "Meningococcal + anaerobic H.i.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Bacterial meningitis in the elderly is typically caused by a limited number of pathogens, with Streptococcus pneumoniae being most common, and Listeria monocytogenes being particularly concerning in older adults and those with comorbidities like diabetes mellitus. The immune system\u2019s decreased efficiency in the elderly, particularly in those with poorly controlled diabetes, predisposes them to infections by encapsulated bacteria. Listeria, an intracellular pathogen, can cross the blood-brain barrier, making it particularly problematic in this population. In elderly patients, meningitis may present atypically, often with altered mental status and less pronounced meningeal signs. Both S. pneumoniae and Listeria are common causative agents in this age group. Recognizing the likely pathogens is critical for initiating appropriate empirical therapy. The differential diagnosis for meningitis includes viral meningitis, other bacterial pathogens such as Neisseria meningitidis, and less commonly, fungal meningitis. A lumbar puncture with CSF analysis (cell count, glucose, protein, Gram stain, culture, and PCR) is essential for prompt diagnosis. Empiric therapy for bacterial meningitis in the elderly usually includes vancomycin plus a third-generation cephalosporin (such as ceftriaxone) with the addition of ampicillin to cover Listeria monocytogenes. For pregnant patients, adjustments are made to ensure safety, such as using ampicillin and ceftriaxone, while avoiding potentially teratogenic agents. Option A (Listeria + strep + pneumonic) is correct as it broadly reflects the fact that in the elderly with poorly controlled diabetes, the most common causative organisms are Listeria monocytogenes and Streptococcus pneumoniae. Option B (HIV + Cryptococcus) is typical for immunocompromised patients with HIV, and option C (Meningococcal + anaerobic H.i.) do not align with the typical microbiological profile in this patient population. 1. In patients over 50 or with immunocompromising conditions like diabetes, always cover for Listeria when treating meningitis. 2. Empirical therapy should address the most likely pathogens, notably S. pneumoniae and Listeria monocytogenes. 3. Early recognition and treatment are essential to reduce morbidity and mortality. Recent guidelines from the Infectious Diseases Society of America (IDSA) reinforce the need for empiric coverage of Listeria in elderly patients. Studies continue to support the combination of ampicillin with standard empiric regimens to improve outcomes in this demographic.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Commonest site of VZV infection in neuraxis is?",
    "option_a": "Thoracic",
    "option_b": "Cervical",
    "option_c": "Lumbar",
    "option_d": "Sacral",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Varicella-zoster virus (VZV) causes chickenpox as a primary infection and later reactivates to produce herpes zoster (shingles). The virus remains dormant in the sensory dorsal root ganglia after primary infection. Upon reactivation, VZV travels along the sensory nerve from the dorsal root ganglia to the corresponding dermatome. Due to the anatomic distribution of the dorsal root ganglia, the thoracic region (dorsal thoracic ganglia) is most commonly involved. Clinically, herpes zoster presents as a painful, unilateral, vesicular rash confined to a single dermatome. The thoracic dermatome is most frequently affected, leading patients to present with a band-like distribution of lesions on the trunk. The diagnosis is usually clinical, based on the characteristic rash and patient history. Differential diagnoses include herpes simplex virus infection and contact dermatitis, but these conditions have distinct features such as lesion distribution and recurrence patterns. Laboratory confirmation may include PCR or serological tests if needed. Early antiviral therapy (e.g., acyclovir, valacyclovir, or famciclovir) is the mainstay treatment to reduce the duration and severity of herpes zoster and to reduce the risk of postherpetic neuralgia. Treatment should ideally begin within 72 hours of rash onset. In pregnant or lactating patients, antivirals (preferably acyclovir, which has a well-established safety profile in pregnancy) may be considered if the benefits outweigh the risks. Option A (Thoracic) is correct because the thoracic dermatomes (especially between T3 and T12) are the most common sites for herpes zoster reactivation. Options B (Cervical), C (Lumbar), and D (Sacral) are less commonly involved. 1. Herpes zoster typically follows a dermatomal pattern and is most common in the thoracic region. 2. Early initiation of antiviral therapy within 72 hours is key to reducing complications. 3. The incidence of postherpetic neuralgia increases with age. Recent clinical guidelines emphasize early antiviral treatment to mitigate the severity of herpes zoster and its complications. Studies continue to support the safety and efficacy of acyclovir, especially in populations such as pregnant women where careful risk-benefit analysis is required.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "HIV patient on HAART but not compliant, presented with confusion, brain MRI shows parieto-occipital and cerebellar T2 signals in flair with no enhancement. Best treatment?",
    "option_a": "Antiretroviral therapy",
    "option_b": "Acyclovir",
    "option_c": "Steroid",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This scenario describes Progressive Multifocal Leukoencephalopathy (PML), a demyelinating brain disease caused by the JC virus that primarily affects immunocompromised patients, notably those with HIV who are not compliant with HAART. JC virus, normally latent in the majority of the population, reactivates in severely immunocompromised patients. It infects oligodendrocytes, leading to widespread demyelination. The MRI findings\u2014T2/FLAIR hyperintensities in parieto\u2010occipital and cerebellar regions without contrast enhancement\u2014are classic for PML, reflecting the lack of a robust inflammatory blood\u2013brain barrier breakdown. Patients with PML often present with subacute neurological deficits such as confusion, altered mental status, motor weakness, visual changes, and ataxia. The absence of contrast enhancement on MRI helps distinguish PML from other inflammatory or neoplastic lesions where a breakdown of the blood\u2013brain barrier would typically occur. Diagnosis is based on clinical presentation, MRI characteristics, and can be further supported by CSF polymerase chain reaction (PCR) for JC virus. Differential diagnoses include cerebral toxoplasmosis (which typically shows ring-enhancing lesions), primary CNS lymphoma (often with mass effect and enhancement), and other demyelinating disorders like multiple sclerosis. The cornerstone of PML management is immune reconstitution. In HIV patients, the best treatment is effective antiretroviral therapy (ART) to restore immune function. There is no proven antiviral or immunomodulatory treatment specifically for JC virus. In pregnant or lactating women with HIV, current guidelines advise the use of ART while carefully monitoring maternal and fetal outcomes, as ART has been shown to reduce perinatal HIV transmission and improve maternal health. Option A (Antiretroviral therapy) is correct because restoring immune function is critical for halting the progression of PML. Option B (Acyclovir) is incorrect since it targets herpes viruses, not JC virus. Option C (Steroid) is not indicated as steroids may further suppress the immune response and worsen the condition. Option D is not provided. 1. Non-enhancing white matter lesions on MRI in an HIV patient strongly suggest PML. 2. Early initiation or optimization of ART is the most effective management strategy. Recent research continues to explore adjunctive therapies such as immune checkpoint inhibitors, but the mainstay remains optimal ART. Updated guidelines reinforce ART as the only proven method to improve outcomes in PML.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_7.png"
  },
  {
    "question": "Typical scenario of nasal mucormycosis in diabetic patient. What is the treatment?",
    "option_a": "Amphotericine",
    "option_b": "Praziquantil",
    "option_c": "Fluconazole",
    "option_d": "Steroid",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Nasal mucormycosis is an invasive fungal infection typically seen in patients with poorly controlled diabetes. The disease is caused by fungi belonging to the order Mucorales. Hyperglycemia with ketoacidosis creates an environment favorable for fungal proliferation. Impaired neutrophil function in diabetic patients facilitates tissue invasion. Mucor species invade blood vessels, leading to thrombosis and tissue necrosis, which can manifest as black necrotic eschars in the nasal cavity. Clinically, patients present with facial pain, nasal congestion, and tissue necrosis. Early diagnosis is crucial since the infection can rapidly extend to the orbit and brain, resulting in high morbidity and mortality. Diagnosis is usually made by a combination of imaging (CT/MRI demonstrating sinus involvement), direct tissue biopsy, and fungal staining/culture. Differentials include invasive aspergillosis and bacterial sinusitis, which can be differentiated by histopathological evaluation and culture results. The first-line treatment is high-dose Amphotericin B (preferably the liposomal formulation) along with urgent surgical debridement of necrotic tissues and aggressive management of underlying conditions (e.g., controlling blood sugar levels). Second-line or adjunctive treatments include posaconazole or isavuconazole. In pregnant or lactating women, Amphotericin B is considered safe (Pregnancy Category B) and is preferred over azoles due to potential teratogenicity of the latter. Option A (Amphotericin) is correct as it is the first-line antifungal for mucormycosis. Option B (Praziquantel) is used for parasitic infections like schistosomiasis, not fungal infections. Option C (Fluconazole) has no activity against Mucorales. Option D (Steroid) is contraindicated as it would further suppress the immune system and worsen the infection. 1. In diabetic patients with sinonasal symptoms and necrotic lesions, consider mucormycosis early. 2. Combined surgical and medical management is essential for survival. Recent guidelines advocate for early aggressive surgical debridement combined with liposomal Amphotericin B. Studies emphasize strict glycemic control and early intervention to improve survival rates in affected patients.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Commonest organism in bacterial meningitis in general?",
    "option_a": "pneumococcal",
    "option_b": "Staph aureus",
    "option_c": "Meningococcal",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Bacterial meningitis is a life-threatening infection of the meninges. Identification of the most common causative organism helps direct empirical antibiotic therapy. Bacterial invasion of the meninges leads to an inflammatory response, increased permeability of the blood-brain barrier, and consequent cerebral edema. The inflammatory response contributes to many of the clinical complications seen in bacterial meningitis. Patients typically present with fever, marked headache, neck stiffness, photophobia, and altered mental status. Early diagnosis and rapid initiation of antibiotics are critical to minimize neurological complications and mortality. The diagnostic approach includes obtaining blood cultures and performing a lumbar puncture for cerebrospinal fluid (CSF) analysis. CSF typically shows a neutrophilic pleocytosis, elevated protein, and low glucose. Differential diagnoses include viral or tubercular meningitis, which have distinct CSF profiles. Empiric treatment for bacterial meningitis in adults generally includes a combination of vancomycin plus a third-generation cephalosporin (e.g., ceftriaxone), with the addition of ampicillin in older patients to cover Listeria monocytogenes. Dexamethasone is also recommended as an adjuvant therapy to reduce inflammation. For pregnant or lactating women, antibiotic choices are guided by safety profiles; for instance, ceftriaxone and vancomycin are generally considered safe, while adjustments may be necessary for Listeria coverage. Option A (Pneumococcal) is correct because Streptococcus pneumoniae is the most common cause of bacterial meningitis in the general (adult) population. Option B (Staph aureus) is generally associated with post-neurosurgical infections rather than community-acquired meningitis. Option C (Meningococcal) is common in adolescents and young adults but overall, in the general population, S. pneumoniae predominates. 1. Streptococcus pneumoniae has the highest mortality among bacterial meningitis pathogens, underscoring the need for prompt treatment. 2. Empiric antibiotic regimens should be tailored to cover the most likely pathogens based on the patient\u2019s age and risk factors. Current guidelines from major societies (such as IDSA) continue to support S. pneumoniae as the leading cause of bacterial meningitis in adults and emphasize early administration of empiric antibiotics along with adjunctive dexamethasone therapy.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "HIV patient come with lumbosacral polyradiculopathy, CSF neutrophils, MRI shows enhanced/thick lumbosacral roots, organism?",
    "option_a": "EBV",
    "option_b": "CMV",
    "option_c": "HSV",
    "option_d": "Lyme",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "This question describes a neurologic complication in an HIV patient presenting with lumbosacral polyradiculopathy. In immunocompromised patients, cytomegalovirus (CMV) is a well-documented cause of polyradiculopathy. CMV can infect the nerve roots and dorsal root ganglia, leading to inflammation, demyelination, and nerve root thickening. The resulting neuritis causes pain, weakness, and sensory deficits in the affected nerve distributions. MRI findings of enhanced and thickened lumbosacral roots support an inflammatory process. Although viral infections typically yield lymphocytic predominance in the CSF, in certain immunocompromised states, the cellular response can be atypical. Patients present with lower extremity weakness, radicular pain, and sometimes bowel or bladder dysfunction. The involvement of lumbosacral roots is classically seen in CMV polyradiculopathy in advanced HIV/AIDS. Diagnosis is based on clinical history, CSF analysis (which may reveal pleocytosis, occasionally with a neutrophilic component in early phases or due to a mixed response), and MRI findings showing thickened and contrast-enhancing nerve roots. Differential diagnoses include Lyme neuroborreliosis (typically with a lymphocytic CSF and history of tick exposure), herpes simplex virus radiculitis, and even neoplastic processes affecting the nerve roots; however, the clinical setting points toward an opportunistic infection with CMV. The primary treatment for CMV polyradiculopathy is antiviral therapy, with intravenous ganciclovir being the first-line agent. Alternatives include foscarnet or cidofovir in cases of ganciclovir resistance or intolerance. In pregnant or lactating women, the use of ganciclovir is challenging due to potential teratogenicity and toxicity; risks and benefits must be carefully weighed with consultation from infectious disease specialists. Option A (EBV) is not typically associated with polyradiculopathy in this context. Option B (CMV) is correct as it is the well-known cause of lumbosacral polyradiculopathy in advanced HIV patients. Option C (HSV) more commonly causes encephalitis or radiculitis associated with herpetic skin lesions (e.g., Elsberg syndrome) but is less likely in this setting. Option D (Lyme) can cause radiculoneuritis; however, it is less common in an HIV patient without a fitting exposure history and typically presents with a lymphocytic rather than neutrophilic CSF. 1. CMV polyradiculopathy should be suspected in HIV patients with lumbosacral symptoms and enhanced nerve root MRI findings. 2. Early antiviral treatment is essential for preventing further neurological deterioration. Recent guideline updates and studies continue to support the use of ganciclovir as first-line therapy for CMV neurological disease in immunocompromised patients, although newer therapies and combination approaches are under investigation to improve outcomes.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_7.png"
  },
  {
    "question": "AIDS patient has confusion, CT contrasted image shows multiple ring enhancing masses in brain, upon performing LP and CSF analysis you should consider sending test for?",
    "option_a": "VZV",
    "option_b": "HSV",
    "option_c": "EBV",
    "option_d": "Cryptococcus antigen",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "In AIDS patients with brain lesions on imaging, the two most important differentials for ring-enhancing lesions are cerebral toxoplasmosis and primary central nervous system (CNS) lymphoma. Cerebral lymphoma, especially primary CNS lymphoma, is strongly associated with Epstein\u2013Barr virus (EBV) in immunocompromised individuals, and its detection in cerebrospinal fluid (CSF) via PCR helps in differentiating it from other causes. Primary CNS lymphoma in AIDS is typically a diffuse large B-cell lymphoma that is driven by EBV infection. In the setting of immunosuppression, latent EBV in B-cells can reactivate, leading to malignant transformation. The presence of EBV DNA in the CSF is a consequence of tumor cell lysis and release of viral genomes. Patients with primary CNS lymphoma often present with focal neurologic deficits, confusion, or other signs of increased intracranial pressure. While toxoplasmosis usually causes multiple lesions, primary CNS lymphoma can occasionally be multifocal as well. Differentiating these is crucial because the management and prognosis differ significantly. After imaging (CT/MRI) reveals ring-enhancing lesions, a lumbar puncture is often performed. In primary CNS lymphoma, CSF analysis demonstrating the presence of EBV DNA (via PCR) is highly suggestive. Differential diagnoses include cerebral toxoplasmosis (diagnosed primarily by serology and response to anti-toxoplasma therapy) and cryptococcal meningitis (diagnosed with cryptococcal antigen testing), as well as other viral encephalitides like HSV, which typically show temporal lobe involvement. Management requires a multidisciplinary approach. First-line treatment for primary CNS lymphoma includes high-dose methotrexate-based chemotherapy protocols, often combined with radiation therapy in selected cases. Initiation or optimization of antiretroviral therapy (ART) is essential. In pregnant or lactating patients, chemotherapy poses significant risks; treatment decisions require balancing maternal benefit and fetal risk with the involvement of maternal-fetal medicine specialists. Option A (VZV) and Option B (HSV) are primarily associated with other CNS infections; HSV typically causes temporal lobe encephalitis, and VZV is more linked to vasculopathy or shingles. Option D (Cryptococcus antigen) is used to diagnose cryptococcal meningitis, which usually presents with meningitis rather than discrete ring-enhancing lesions. Option C (EBV) is the correct laboratory test to consider in this context for diagnosing primary CNS lymphoma in an AIDS patient. 1. In immunocompromised patients, ring-enhancing lesions necessitate a consideration of both toxoplasmosis and primary CNS lymphoma. 2. EBV PCR in the CSF is a valuable diagnostic tool for primary CNS lymphoma. 3. Empiric treatment for toxoplasmosis is often initiated first; lack of clinical improvement may prompt further investigation with CSF EBV PCR. Recent guidelines emphasize early differentiation between toxoplasmosis and primary CNS lymphoma in AIDS patients using a combination of imaging, clinical response to empiric therapy, and molecular tests such as EBV PCR. Studies continue to refine the sensitivity and specificity of CSF EBV testing, and current protocols advocate for a tailored approach in management.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_7.png"
  },
  {
    "question": "most common organism in bacterial meningitis?",
    "option_a": "strept pnemonia",
    "option_b": "Lesteria",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Bacterial meningitis is a life\u2010threatening infection of the meninges. In adults, Streptococcus pneumoniae is the leading cause of community-acquired bacterial meningitis. Bacterial pathogens invade the bloodstream or directly spread to the meninges, triggering an intense inflammatory response. This inflammation disrupts the blood\u2013brain barrier, leading to cerebral edema and neurologic compromise. Patients typically present with high fever, severe headache, neck stiffness, photophobia, and altered mental status. Streptococcus pneumoniae infections rapidly progress and require prompt diagnosis and treatment to reduce mortality and morbidity. Diagnosis is based on clinical presentation and confirmed via lumbar puncture (CSF analysis showing neutrophilic pleocytosis, low glucose, and high protein) along with bacterial culture, Gram stain, and sometimes PCR. Differential diagnoses include viral meningitis (often with a lymphocytic predominance), tuberculous meningitis (with a more subacute course), and fungal meningitis. Empiric antibiotic therapy should be initiated immediately. First-line treatment in adults typically includes vancomycin plus a third-generation cephalosporin (e.g., ceftriaxone). Dexamethasone is recommended as an adjunct in pneumococcal meningitis. For pregnant or lactating women, antibiotic regimens must be chosen with safety profiles in mind (ceftriaxone is generally considered safe, and vancomycin is also acceptable in pregnancy). Option A (Streptococcus pneumoniae) is correct as it is the most common cause of bacterial meningitis in adults. Option B (Listeria) is more common in neonates, older adults, and immunocompromised patients but is not the most common cause overall in the general adult population. Options C and D are not provided; thus, Option A stands as the correct answer. 1. Streptococcus pneumoniae is the leading cause of community-acquired bacterial meningitis in adults. 2. Rapid initiation of empiric antibiotics significantly improves patient outcomes. 3. Dexamethasone adjunct therapy is particularly beneficial in pneumococcal meningitis. Recent studies and updated guidelines reinforce the early use of combination antibiotic therapy and dexamethasone in adults with suspected pneumococcal meningitis. Ongoing research into optimal treatment regimens continues to refine these strategies, especially in populations with special considerations like pregnancy.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "malaria",
    "option_a": "malaria",
    "option_b": "Toxo",
    "option_c": "Brucella",
    "option_d": "Borrellia",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Malaria is a parasitic disease caused by protozoa of the genus Plasmodium and transmitted via the bite of an infected Anopheles mosquito. It is a major public health problem in endemic regions. After transmission, sporozoites enter the bloodstream and quickly invade liver cells, where they multiply. Merozoites released from the liver infect red blood cells, leading to cyclic fevers, hemolysis, and potential severe complications such as cerebral malaria, particularly in Plasmodium falciparum infections. Clinically, patients often experience cyclical episodes of fever, chills, and rigors along with malaise. Severe infections can lead to anemia, splenomegaly, and neurologic manifestations like altered consciousness in cerebral malaria. Diagnosis relies on the examination of thick and thin blood smears with Giemsa staining to visualize the parasite. Rapid diagnostic tests (RDTs) are also widely used. The differential diagnosis includes other causes of febrile illness such as dengue fever, typhoid, and other parasitic infections. First-line therapy for uncomplicated malaria is with artemisinin-based combination therapies (ACTs), such as artemether-lumefantrine, especially in regions with confirmed resistance to older agents like chloroquine. Severe malaria is treated with intravenous artesunate. In pregnant patients, treatment depends on the gestational age; for instance, quinine plus clindamycin is often used during the first trimester, while ACTs can be considered in later trimesters, though consultation with specialists is advised. Lactating women can usually receive ACTs safely. Option A (malaria) is correctly chosen. Option B (Toxoplasma) causes toxoplasmosis and is not transmitted by mosquitoes. Option C (Brucella) is a bacterial zoonosis typically associated with ingestion of unpasteurized dairy products. Option D (Borrelia) causes Lyme disease and relapsing fever, which are tick-borne illnesses, not malaria. 1. Always consider travel history when evaluating febrile illnesses in endemic regions. 2. Malaria\u2019s life cycle with liver and blood stages underpins both its clinical presentation and treatment strategy. 3. Cerebral malaria is a severe complication that requires urgent intervention. Updated World Health Organization guidelines advise the use of ACTs as first-line treatment for uncomplicated malaria due to high rates of resistance to older drugs. Research continues into vaccine development and new pharmacologic strategies to combat emerging drug resistance.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "indian nurse lady came with 1st time seizure, hx of headache one week before, seen in neurology clinical label as tension headache Attached CT Neurocystosercosis",
    "option_a": "tenia solim",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is an infection of the CNS caused by the larval form of Taenia solium, the pork tapeworm. It is the most common parasitic infection of the brain and a major cause of acquired epilepsy worldwide. Humans acquire the infection by ingesting eggs shed in the feces of a tapeworm carrier. The ingested eggs hatch in the intestine, and the larvae disseminate to tissues, including the brain, forming cysticerci. The inflammatory response around the degenerating cysts can lead to seizures and headaches. Patients often present with new-onset seizures, headaches, or other focal neurologic deficits. In endemic regions like parts of India, a history of exposure along with characteristic imaging findings on CT or MRI (such as cystic lesions sometimes with a visible scolex\u2014the 'hole-with-dot' sign) is suggestive of neurocysticercosis. Diagnosis is generally based on neuroimaging (CT or MRI), serologic assays (e.g., enzyme-linked immunoelectrotransfer blot), and clinical findings. Differential diagnoses include brain abscesses, tumors (like metastases or primary lymphoma), and other parasitic infections. The appearance and number of lesions, along with clinical history, help in differentiating these conditions. The cornerstone of management is antiparasitic therapy, most commonly with albendazole (often preferred over praziquantel), combined with corticosteroids (to reduce the inflammatory response) and antiepileptic drugs for seizure control. In pregnant patients, the use of antiparasitics is controversial, particularly in the first trimester, and management is individualized weighing risks and benefits. Lactating women are generally managed similarly to non-lactating adults, although safety profiles of medications should be reviewed. Option A (Taenia solium) is the correct etiologic agent in neurocysticercosis. The other options are either not provided or represent organisms causing different diseases. Accurate identification is critical for appropriate treatment. 1. Neurocysticercosis is a leading cause of adult-onset seizures in endemic areas. 2. Characteristic imaging findings (such as the scolex in a cyst) are key to diagnosis. 3. Management requires a combination of antiparasitic treatment, steroids, and seizure control. Recent guidelines support the use of albendazole as first-line therapy for neurocysticercosis and emphasize the importance of tailoring treatment to the stage and burden of infection. Emerging research is focusing on optimizing dosing regimens and the role of combination therapies to improve outcomes while minimizing side effects.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "long history pt came with seizure and flaccid paralysis?",
    "option_a": "WNV",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "West Nile Virus (WNV) is a mosquito\u2010borne flavivirus that in its neuroinvasive form can present with encephalitis and an acute flaccid paralysis syndrome. The combination of seizures (a feature of encephalitis) and flaccid paralysis (due to involvement of anterior horn cells, mimicking poliomyelitis) is a classic presentation of severe WNV infection. WNV invades the central nervous system after peripheral replication and can infect neurons, leading to neuronal injury. Direct viral cytopathic effects and subsequent inflammatory responses cause encephalitis (with potential seizure activity) and acute flaccid paralysis by targeting anterior horn cells. This dual manifestation is well documented in patients with neuroinvasive disease. Patients infected with WNV may initially develop fever, headache, and malaise. In severe cases, the involvement of the brain parenchyma results in encephalitis (which can present as altered mental status and seizures), and infection of the spinal cord anterior horn cells produces a poliomyelitis\u2013like flaccid paralysis. This combination guides the clinician to consider WNV in endemic areas especially during summer and early fall. Diagnosis involves a high index of suspicion supported by laboratory findings. Cerebrospinal fluid (CSF) analysis may reveal lymphocytic pleocytosis and elevated protein. Detection of WNV\u2010specific IgM antibodies in the serum or CSF via ELISA is a key diagnostic step. Differential diagnoses include other viral encephalitides (such as Eastern equine encephalitis, Japanese encephalitis), poliovirus infection, and other causes of acute flaccid paralysis like Guillain\u2013Barr\u00e9 syndrome. There is no specific antiviral therapy approved for WNV; therefore, treatment is predominantly supportive. Management includes supportive care in an intensive care setting where needed, seizure management with antiepileptics, and respiratory support if paralysis affects breathing. In pregnancy and lactation, supportive treatment remains the mainstay, as no specific therapy has demonstrated safety concerns unique to these populations, though careful monitoring is advised. Option A (WNV) is correct because it is the most recognized viral pathogen that can cause both seizures (due to encephalitis) and flaccid paralysis (due to anterior horn cell involvement). Other options were not provided, but none would fit the characteristic dual presentation as accurately. 1. Neuroinvasive WNV typically presents during summer and early fall in endemic regions. 2. The flaccid paralysis seen in WNV can mimic poliomyelitis but is accompanied by encephalitic features like seizures. 3. Supportive care is the cornerstone of management, as no specific antiviral therapy exists. Recent studies affirm that early recognition and supportive management are key in handling neuroinvasive WNV. There is ongoing research into potential antiviral and immunomodulatory treatments, though none have yet supplanted supportive care in clinical guidelines.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "most common organism of polyradiculopathy?",
    "option_a": "CMV",
    "option_b": "In HIV CMV",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Polyradiculopathy involves dysfunction of multiple nerve roots and can be due to infectious etiologies, especially in immunocompromised individuals. Cytomegalovirus (CMV) is a well\u2010recognized pathogen that can cause a polyradiculopathy, particularly in patients with advanced HIV/AIDS. In immunocompromised individuals, reactivation of CMV leads to direct viral invasion and inflammation of nerve roots. This results in demyelination and axonal injury, causing significant motor and sometimes sensory deficits. The virus\u2019s predilection for nervous tissue in such patients explains the propensity for developing polyradiculopathy. Patients, especially those with AIDS, may present with severe pain, weakness (often in the lower extremities), and diminished reflexes in a pattern consistent with radiculopathy. These clinical findings, combined with the immunocompromised state, point toward a CMV etiology. Diagnosis relies on a combination of clinical suspicion and specialized testing. CSF analysis may reveal an elevated protein level with mild pleocytosis. Polymerase chain reaction (PCR) testing for CMV DNA in the CSF can help confirm the diagnosis. Differential diagnoses include Guillain\u2013Barr\u00e9 syndrome, HIV-associated neuropathy, and other infectious causes (e.g., varicella zoster virus radiculopathy), which can be differentiated by virological studies and clinical context. The mainstay of treatment is antiviral therapy, primarily with ganciclovir or foscarnet. Given the potential toxicity of these drugs, therapy must be carefully monitored. For patients who are pregnant, the risks and benefits of antiviral therapy should be carefully weighed, as ganciclovir is generally contraindicated or used with extreme caution due to possible fetal toxicity. Supportive care and rehabilitation are also important. Option A (CMV) is correct because CMV is the most common infectious agent implicated in polyradiculopathy among immunocompromised individuals. Option B, which specifies \u201cIn HIV CMV,\u201d essentially conveys the same causative agent but with additional context. Since the question asks for the organism, CMV is the correct answer. Other options were not provided. 1. In patients with advanced HIV/AIDS, always consider CMV as a cause of polyradiculopathy. 2. Early recognition and prompt initiation of antiviral therapy can be crucial, although the overall prognosis remains guarded. 3. CSF PCR is a valuable diagnostic tool in these cases. Recent guidelines emphasize prompt diagnostic evaluation (including PCR for CMV) in immunocompromised patients with polyradiculopathy. Despite limited randomized controlled trials specific to CMV radiculopathy, expert consensus supports early antiviral intervention with agents such as ganciclovir or foscarnet.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "What is the prevention of postherpatic neuralgia??",
    "option_a": "Antiviral",
    "option_b": "Topical lidocain",
    "option_c": "Steroid",
    "option_d": "Antiviral ?",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Neuro-infectious",
    "explanation": "Postherpetic neuralgia (PHN) is a chronic neuropathic pain syndrome that occurs as a complication of herpes zoster (shingles). Its prevention is largely focused on mitigating nerve damage during the acute viral phase. Herpes zoster results from reactivation of latent varicella zoster virus in dorsal root ganglia. The resultant inflammation and direct viral damage to the nerves can cause lasting neural injury, leading to PHN. Early administration of antiviral agents helps reduce viral replication and inflammation, thereby potentially reducing nerve damage. Clinically, patients with shingles develop a painful, unilateral vesicular rash. When the virus causes significant neural injury, the pain can persist for months to years after the rash has healed, which constitutes PHN. Preventing this progression is primarily based on timely antiviral intervention. PHN is diagnosed based on clinical history\u2014persistent pain (usually burning or stabbing in quality) following the resolution of a shingles rash, typically lasting more than 90 days. Differential diagnoses include other causes of neuropathic pain, such as diabetic neuropathy or post-traumatic neuralgia, which can be differentiated by history and clinical exam. The primary prevention measure for PHN is early initiation of antiviral therapy (such as acyclovir, valacyclovir, or famciclovir) ideally within 72 hours of rash onset. Antivirals help reduce viral replication and nerve damage. Additional measures may include pain management strategies and, in some cases, adjunctive corticosteroids, although steroids have not been definitively proven to prevent PHN. In pregnant or lactating women, acyclovir is considered relatively safe (pregnancy category B); however, decisions should be individualized based on the risk-benefit ratio. Option D (Antiviral) is correct because early antiviral therapy has been shown to reduce the incidence and severity of PHN. Option A, which also states \u201cAntiviral,\u201d is essentially the same answer; however, the marked answer was D. Options B (Topical lidocaine) and C (Steroid) are used for symptomatic relief or adjunctive pain control but are not primary preventive measures for PHN. 1. Initiate antiviral therapy within 72 hours of rash onset to reduce the risk of developing PHN. 2. Vaccination against shingles in older adults is an effective preventive measure against both shingles and its complications. 3. Adjunctive pain management strategies are important but do not replace early antiviral intervention. Recent clinical guidelines reaffirm that early antiviral therapy in acute herpes zoster is critical in reducing the incidence of PHN. Studies continue to explore optimal dosing and timing, and the shingles vaccine remains a major preventive strategy among older adults.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Pt came with headache / vomiting/ fever and nuckal regidity, 2 weeks back she had decompressive craniotomy due to chairi. What is the organism??",
    "option_a": "staph",
    "option_b": "Strept",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Following neurosurgical procedures, such as decompressive craniotomy, patients are at risk for nosocomial (hospital-acquired) infections including postoperative meningitis. Staphylococcal species, particularly Staphylococcus aureus and coagulase-negative staphylococci, are among the most common pathogens in this setting. Postoperative meningitis occurs when pathogens, often from the skin flora, gain access to the central nervous system during or after surgery. Disruption of the normal protective barriers of the dura or the introduction of foreign material (e.g., surgical hardware) can facilitate infection. Staphylococcus species are well adapted to colonize skin and surgical sites, making them frequent culprits. A patient presenting with headache, vomiting, fever, and neck stiffness (nuchal rigidity) in the postoperative period is highly suggestive of meningitis. The timing (2 weeks post-surgery) aligns well with the typical presentation of nosocomial meningitis rather than community-acquired forms, where different pathogens (e.g., Streptococcus pneumoniae) are more common. The diagnostic workup involves lumbar puncture (LP) with CSF analysis, which typically shows a neutrophilic pleocytosis, elevated protein, and decreased glucose in bacterial meningitis. Gram stain and culture of the CSF are critical to identify the causative organism. Differential diagnoses include meningitis due to Gram-negative organisms (like Acinetobacter or Pseudomonas) and atypical pathogens; however, the postoperative setting makes staphylococcal infection more likely. Empiric antibiotic therapy should cover both staphylococcal species (using agents such as vancomycin) and Gram-negative pathogens until definitive culture results are available. The choice of antibiotics must be adjusted according to sensitivity patterns. In pregnant or lactating patients, while vancomycin is generally classified as category C, it may be used when the benefits outweigh the risks, with additional support and monitoring as needed. Option A (Staph) is correct because staphylococcal species are the most common cause of postoperative meningitis following neurosurgical procedures. Option B (Streptococcus) is more typically associated with community-acquired meningitis. Options C and D were not provided, making Option A the best answer in this context. 1. Postoperative meningitis should be suspected in any neurosurgical patient with fever, headache, vomiting, and nuchal rigidity. 2. Early CSF analysis via lumbar puncture is crucial to guide appropriate antimicrobial therapy. 3. Empiric therapy must cover both staphylococcal and Gram-negative organisms until culture sensitivities are known. Contemporary neurosurgical guidelines emphasize early recognition and prompt, broad-spectrum empiric antimicrobial therapy for postoperative meningitis. There is ongoing research into optimizing prophylactic strategies during neurosurgical procedures to reduce the incidence of these infections, with staphylococcal coverage remaining a mainstay of perioperative prophylaxis.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Diagnoses with NPH scenario but patient had abdomen TB what to do",
    "option_a": "3rd ventriculostomy",
    "option_b": "Omymma reservoir",
    "option_c": "Acetazolamide",
    "option_d": "Topiramate",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This question deals with managing a patient who presents with features of hydrocephalus (often seen in a normal pressure hydrocephalus [NPH] scenario) but who also has active abdominal tuberculosis. Typically, a ventriculoperitoneal (VP) shunt is used to treat NPH. However, in the setting of abdominal TB, seeding the peritoneum with a shunt is relatively contraindicated, so an alternative CSF diversion procedure that avoids the infected peritoneal cavity is required. Tuberculous meningitis can lead to hydrocephalus by causing inflammatory exudates at the base of the brain, resulting in impaired CSF flow. When the peritoneum is also involved with TB, using it as a drainage site (as in a VP shunt) risks infection of the implanted hardware and shunt failure. Endoscopic third ventriculostomy (ETV) (or 3rd ventriculostomy) creates an opening in the floor of the third ventricle to allow CSF to bypass the obstructed pathways, thus relieving the hydrocephalus without using the peritoneal cavity. Patients with TB meningitis may show clinical features of hydrocephalus (gait disturbances, cognitive impairment, urinary incontinence) alongside signs of systemic or abdominal TB. Imaging studies (CT/MRI) help determine the type of hydrocephalus (communicating vs. obstructive) and guide the surgical approach, particularly when standard VP shunt placement is inadvisable due to abdominal involvement. Work-up includes neuroimaging (CT/MRI) to assess ventricle size and CSF flow, and CSF analysis in suspected TB meningitis. Differential diagnoses include other causes of hydrocephalus such as aqueductal stenosis or idiopathic NPH. In this scenario, differentiating an obstructive component (which may benefit from third ventriculostomy) versus a purely communicating hydrocephalus is crucial. First-line management of TB meningitis includes anti-tubercular therapy (ATT) and corticosteroids. When hydrocephalus requires surgical intervention and the peritoneal cavity is a poor option due to abdominal TB, ETV (third ventriculostomy) is a viable alternative. For patients of childbearing age or who are pregnant/lactating, surgical interventions are considered urgent when indicated, with anesthetic planning that minimizes fetal risk. The decision for ETV versus VP shunt is based on radiological findings and the patient\u2019s overall TB status. Option A (3rd ventriculostomy) is the correct choice because it avoids the peritoneal cavity and provides CSF diversion in patients where VP shunt placement is contraindicated due to abdominal TB. Option B (Ommaya reservoir) is typically used for intraventricular drug administration or intermittent CSF sampling rather than long\u2010term diversion. Options C (Acetazolamide) and D (Topiramate) are medications that may influence CSF dynamics but are not standard definitive treatments for hydrocephalus in this context. \u2022 In patients with TB, always consider that abdominal TB may preclude the use of a VP shunt.  \u2022 Endoscopic third ventriculostomy is particularly useful in cases where conventional peritoneal CSF shunting is contraindicated.  \u2022 Radiographic assessment is crucial to decide if the anatomy is favorable for ETV. Recent studies in TB meningitis-related hydrocephalus have shown that while VP shunting remains standard, in patients with abdominal co-morbidities (like active TB), ETV is a feasible alternative. Although success rates can vary based on the extent of basal exudates, the evolving role of neuroendoscopy supports its use in this subset of patients.",
    "exam_year": "2022",
    "exam_type": "Part I"
  }
]